Connect with us

Announcements

Are Cannabinoid Isolates the Next Wave to Unfold in the Cannabis Green Rush Era?

Published

on

Are Cannabinoid Isolates the Next Wave to Unfold in the Cannabis Green Rush Era?

One company, Global Cannabinoids, is making headway in the CBD industry with its release of a 2020 catalog featuring hemp-derived isolates, oils, and finished products.

Global Cannabinoids appears to also be working on its consumer platform, which would allow consumers to purchase business to business products online. Ryan Lewis, CEO Global Cannabinoids in a NutraIngredients-USA report explained,

“One of the ways I’ve been scaling my operation is by leveraging technology to make purchasing more seamless and user-friendly. We were actually approached by Shopify to use their technology to custom make a platform for us using their software so we could offer our customers a B2B solution to order products online.”

As for the products offered on the platform, CBD and rare cannabinoids are a few of the options that buyers may encounter. The rare cannabinoids are made possible by the new insight concerning cannabinoids and technology. Lewis told NutraIngredients-USA,

“The trend right now is CBD, but you’re going to start to see a lot more of what I call ‘rare cannabinoids’, and they’re rare because the plant doesn’t produce them in very large quantities. We’re learning more and more about these cannabinoids and the technology is now allowing us to isolate and produce these more rare cannabinoids in larger amounts.”

The company also uses a specific extraction process for its products.

“The way that we isolate cannabinoids is that we first do an initial extraction, which is usually C02 or you can also use ethanol. You essentially want to get the oil out of the plant. That is what we call a crude oil. It still contains chlorophyll, lipids, and waxes from the plant. When doing an initial extract, that crude oil is really a whole plant profile. From there it goes into a process called winterization and decarboxylation. When you heat it up to a certain temperature, the cannabinoids within the plant, which is CBDA in abundance, converts into CBD. Then the winterization process is essentially freezing the oil, removing a lot of the fat and the waxes.”

Although it appears that Global Cannabinoids is certainly placing a great deal of attention and focus on its new catalog and product offerings, it is also looking ahead at what may just be the upcoming trend, which it suggests will be CBN. Lewis stated,

“CBD might be hot today, but I think the next hot cannabinoid is CBC and CBN. You’re going to see a lot more products coming to market with these other cannabinoids. The bottom line is, we’re dealing with the most medicinal plant on earth.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or medical advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.